FDA approves first coagulation factor-albumin fusion protein to treat patients with hemophilia B

4 March 2016 - Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm489266.htm

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Blood product